SARTANS AND ANGIOTENSIN CONVERTING ENZYME INHIBITORS: A DUEL BETWEEN TWO LEADERS OF PHARMACOTHERAPY OF CARDIOVASCULAR DISEASES

Topical issues of cardiovascular disease pharmacotherapy influencing function of the renin-angiotensin-aldosterone system are discussed. Efficacy and safety of two major cardiovascular drug classes, angiotensin converting enzyme inhibitors and sartans, are compared. Data from evidence base of the bo...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: K. A. Gyamdzhyan, M. L. Maksimov
פורמט: Artigo
שפה:Inglês
יצא לאור: Stolichnaya Izdatelskaya Kompaniya 2015-12-01
סדרה:Racionalʹnaâ Farmakoterapiâ v Kardiologii
נושאים:
renin-angiotensin-aldosterone system
sartans
angiotensin converting enzyme inhibitors
pharmacotherapy of cardiovascular diseases
captopril
enalapril
ramipril
losartan
valsartan
irbesartan
endothelial function
atherosclerosis
גישה מקוונת:https://www.rpcardio.com/jour/article/view/644
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים